艾迪药业
(688488)
| 流通市值：64.55亿 | | | 总市值：64.55亿 |
| 流通股本：4.21亿 | | | 总股本：4.21亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 365,854,758.25 | 178,023,123.63 | 719,170,347.67 | 552,400,249.88 |
| 营业总成本 | 334,577,150.84 | 163,507,908 | 687,867,655.52 | 538,614,945.79 |
| 其他经营收益 | | | | |
| 营业利润 | 40,824,600.78 | 18,138,656.82 | 48,082,607.34 | 28,471,365.71 |
| 利润总额 | 37,031,904.19 | 15,846,343.79 | 24,640,777.77 | 26,622,927.66 |
| 净利润 | 32,170,963.33 | 14,189,172.71 | 8,083,067.42 | 16,111,868.23 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 32,170,963.33 | 14,189,172.71 | 8,083,067.42 | 16,111,868.23 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,001,471,322.35 | 1,012,699,506.98 | 938,737,986.93 | 895,789,995.3 |
| 非流动资产: | | | | |
| 非流动资产合计 | 973,552,664.27 | 1,046,189,419.62 | 973,859,997.77 | 949,153,115.4 |
| 资产总计 | 1,975,023,986.62 | 2,058,888,926.6 | 1,912,597,984.7 | 1,844,943,110.7 |
| 流动负债: | | | | |
| 流动负债合计 | 616,049,413.74 | 675,684,338.44 | 709,209,623.57 | 631,918,655.62 |
| 非流动负债: | | | | |
| 非流动负债合计 | 384,603,392.29 | 293,575,200.13 | 130,161,133.46 | 131,048,185.32 |
| 负债合计 | 1,000,652,806.03 | 969,259,538.57 | 839,370,757.03 | 762,966,840.94 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 914,825,712.19 | 974,509,651.02 | 964,679,378.88 | 978,028,930.96 |
| 股东权益合计 | 974,371,180.59 | 1,089,629,388.03 | 1,073,227,227.67 | 1,081,976,269.76 |
| 负债和股东权益合计 | 1,975,023,986.62 | 2,058,888,926.6 | 1,912,597,984.7 | 1,844,943,110.7 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 420,621,690.73 | 209,749,875.51 | 864,199,104.52 | 622,963,170.44 |
| 经营活动现金流出小计 | 395,561,539.89 | 208,856,030.69 | 846,567,603.75 | 595,474,343.31 |
| 经营活动产生的现金流量净额 | 25,060,150.84 | 893,844.82 | 17,631,500.77 | 27,488,827.13 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 110,509,980.44 | 80,382,220.95 | 396,595,782.58 | 315,741,499.87 |
| 投资活动现金流出小计 | 151,767,661.67 | 37,834,953.98 | 423,224,622.84 | 310,195,450.04 |
| 投资活动产生的现金流量净额 | -41,257,681.23 | 42,547,266.97 | -26,628,840.26 | 5,546,049.83 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 496,924,000 | 328,380,000 | 477,924,000 | 371,924,000 |
| 筹资活动现金流出小计 | 456,957,229.6 | 246,759,893.27 | 427,886,013.13 | 392,151,793.53 |
| 筹资活动产生的现金流量净额 | 39,966,770.4 | 81,620,106.73 | 50,037,986.87 | -20,227,793.53 |
| 汇率变动对现金及现金等价物的影响 | -164,972.9 | -71,035.3 | -101,064.52 | -47,703.57 |
| 现金及现金等价物净增加额 | 23,604,267.11 | 124,990,183.22 | 40,939,582.86 | 12,759,379.86 |
| 期末现金及现金等价物余额 | 388,803,382.74 | 490,189,298.85 | 365,199,115.63 | 337,018,912.63 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 23,604,267.11 | - | 40,939,582.86 | - |